Hematologic Malignancies and Cellular Therapy

Sandeep S. Dave, MD

Professor of Medicine
Member of the Duke Cancer Institute
Campus mail 101 Science Drive, CIEMAS 2177C, Box 3382, Durham, NC 27710
Phone (919) 681-1922
Email address sandeep.dave@duke.edu

Education and Training

  • Fellow in Hematology-Oncology, Medicine, National Institutes of Health, 2001 - 2007
  • Medical Resident, Medicine, Northwestern University, 1999 - 2001
  • M.D., Northwestern University, 1999

Grants

Publications

Lee, Michelle J., Jean L. Koff, Jeffrey M. Switchenko, C Ileen Jhaney, R Andrew Harkins, Sharvil P. Patel, Sandeep S. Dave, and Christopher R. Flowers. “Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma.” Cancer 126, no. 15 (August 1, 2020): 3493–3503. https://doi.org/10.1002/cncr.32866.

PMID
32469082
Full Text

Fedoriw, Yuri, Sara Selitsky, Nathan D. Montgomery, Sviatoslav M. Kendall, Kristy L. Richards, Wei Du, Tamiwe Tomoka, et al. “Identifying transcriptional profiles and evaluating prognostic biomarkers of HIV-associated diffuse large B-cell lymphoma from Malawi.” Mod Pathol 33, no. 8 (August 2020): 1482–91. https://doi.org/10.1038/s41379-020-0506-3.

PMID
32080349
Full Text

Shingleton, Jennifer R., and Sandeep S. Dave. “Polatuzumab Vedotin: Honing in on Relapsed or Refractory Diffuse Large B-Cell Lymphoma.” J Clin Oncol 38, no. 2 (January 10, 2020): 166–68. https://doi.org/10.1200/JCO.19.02587.

PMID
31770050
Full Text

Holkova, B., D. Shafer, V. Yazbeck, S. Dave, P. Bose, M. B. Tombes, E. Shrader, et al. “Phase 1 study of belinostat (PXD-101) and bortezomib (Velcade, PS-341) in patients with relapsed or refractory acute leukemia and myelodysplastic syndrome.” Leukemia and Lymphoma, January 1, 2020. https://doi.org/10.1080/10428194.2020.1861270.

Full Text

Li, Xiang, Rachel Kositsky, Anupama Reddy, Cassandra Love, Kikkeri Naresh, Jean L. Koff, Ilja Nystrand, et al. “Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma.” Blood 134, no. Supplement_1 (November 13, 2019): 19. https://doi.org/10.1182/blood-2019-130255.

PMID
31723982
Full Text

Panea, Razvan I., Cassandra L. Love, Jennifer R. Shingleton, Anupama Reddy, Jeffrey A. Bailey, Ann M. Moormann, Juliana A. Otieno, et al. “The whole-genome landscape of Burkitt lymphoma subtypes.” Blood 134, no. 19 (November 7, 2019): 1598–1607. https://doi.org/10.1182/blood.2019001880.

PMID
31558468
Full Text

Elbaek, Mette Vestergaard, Mette Ølgod Pedersen, Marie Fredslund Breinholt, Anupama Reddy, Cassandra Love, Erik Clasen-Linde, Helle Knudsen, et al. “PD-L1 expression is low in large B-cell lymphoma with MYC or double-hit translocation.” Hematol Oncol 37, no. 4 (October 2019): 375–82. https://doi.org/10.1002/hon.2664.

PMID
31408531
Full Text

Van Mater, David, Eric Xu, Anupama Reddy, Leonor Añó, Mohit Sachdeva, Wesley Huang, Nerissa Williams, et al. “Injury promotes sarcoma development in a genetically and temporally restricted manner.” Jci Insight 3, no. 20 (October 18, 2018). https://doi.org/10.1172/jci.insight.123687.

PMID
30333301
Full Text

Manzano, Mark, Ajinkya Patil, Alexander Waldrop, Sandeep S. Dave, Amir Behdad, and Eva Gottwein. “Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma.” Nat Commun 9, no. 1 (August 15, 2018): 3263. https://doi.org/10.1038/s41467-018-05506-9.

PMID
30111820
Full Text

Pages